| INTRODUCTION |
Interleukin 2 (IL-2) is a pleiotropic cytokine produced primarily by mitogen- or antigen-activated T lymphocytes (1, 2). Human IL-2 (also known as T-cell growth factor) is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 is a potent lymphoid cell growth factor which exerts its biological activity primarily on T cells promoting proliferation and maturation.
IL-2 has been found to stimulate growth and differentiation of B cells, NK cells, LAK cells, monocytes, and oligodendocytes. IL-2 is involved in treatment of cancers such as melanoma and renal cell cancer. It plays a key role in promoting the clonal expansion of antigen-specific T cells. In addition, IL-2 has also been shown to mediate multiple immune responses on a variety of cell types.
At the amino acid sequence level, there is approximately 72% similarity between mature porcine and human IL-2.
The biological effects of IL-2 are mediated by specific cell surface receptor complexes. The functional high-affinity receptor for IL-2 is composed of three distinct polypeptide chains (3, 4).
IL-2 stimulates the proliferation of thymocytes; stimulates the proliferation and differentiation of activated B cells; promotes the growth, differentiation and cytocidal activity of monocytes; induces the growth of natural killer cells and stimulates cytokine production by these cells as well as the cytolytic activity of these cells; enhances the production of lymphocyte-activated killer (LAK) cells; and induces the proliferation and differentiation of oligodendrocytes (1, 2).
|
||||||||||
| PRINCIPLE OF THE ASSAY |
This assay employs the quantitative sandwich enzyme immunoassay technique. A monoclonal antibody specific for IL-2 has been pre-coated onto a microplate. Standard, control, or sample and the working solution of Biotin-Conjugate are pipetted into the wells. Following incubation and wash steps,any IL-2 present is bound by the immobilized antibody and the detection antibody specific for IL-2 is binds to the combination of capture antibody-IL-2 in sample. Following a wash to remove any unbound combination, and enzyme conjugate is added to the wells. Following incubation and wash steps a substrate is added. A coloured product is formed in proportion to the amount of IL-2 present in the sample. The reaction is terminated by addition of acid and absorbance is measured at 450nm. A standard curve is prepared from seven IL-2 standard dilutions and IL-2 sample concentration determined.
Figure 1:Schematic diagram of the assay
|
||||||||||
| REAGENTS |
1. Aluminium pouches with a Microwell Plate coated with antibody to Swine IL-2 (812)
2. 2 vials Swine IL-2 Standard lyophilized, 1500 pg/ml upon reconstitution
3. 2 vials concentrated Biotin-Conjugate anti-Swine IL-2 antibody
4. 2 vials Streptavidin-HRP solution,
5. 1 bottle Standard /sample Diluent
6. 1 bottle Biotin-Conjugate antibody Diluent
7. 1 bottle Streptavidin-HRP Diluent
8. 1 bottle Wash Buffer Concentrate 20x (PBS with 1% Tween-20)
9. 1 vial Substrate Solution
10. 1 vial Stop Solution
11. 4 pieces Adhesive Films
12. package insert
NOTE: [96 Tests]
|
||||||||||
| STORAGE |
Unopened Kit:Store at 2 -8° C. Do not use past kit expiration date. opened/ReconstitutedReagents:Please refer to the datasheets for detail information.
|
||||||||||
| REFERENCES |
1. Goldsmith, M.A. and W.C. Greene (1994) in The Cytokine Handbook, 2nd ed.,
2. Thomson, A. ed., Academic Press, New York, p. 57.
3. Kashima, N. et al. (1985) Nature 313:401.
4. Seigel, L.J. et al. (1984) Science 223:175.
|
||||||||||
| Related Products |
|
Related recommendations
